new IV bisphosphonate called Zometa (zoledronic acid)

Novartis is now marketing a new IV bisphosphonate called Zometa (zoledronic acid).

It will be used as an alternative to Aredia (pamidronate)...for hypercalcemia and bone metastases in cancer patients.

Bisphosphonates lower serum calcium by inhibiting bone resorption. They also reduce bone pain and fractures due to bone metastases.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote